Hao Tian Development Group Limited announced that Dr. Wang Yu and Dr. Li Yao have been appointed as non-executive Directors with effect from 18 August 2020. Dr. Wang, aged 62, has extensive connection and possesses decades of experience in the healthcare space in the People's Republic of China. He is a highly recognized scholar who previously served as the director of Institute of Hepatology, Peking University Health Science Center (formerly known as Beijing Medical University). Dr. Li, aged 51, has over 25 years of experience in financial industry. He has been working for International Finance Corporate of World Bank Group since 1999 and he currently is the Regional Chief Investment Officer for East Asia and Pacific of IFC. Dr. Li also serves as an independent director of 21Vianet Group Inc.